Literature DB >> 8742434

Transport of hydrophobized fragments of antibodies through the blood-brain barrier.

V P Chekhonin1, I A Ryabukhin, Y A Zhirkov, I A Kashparov, T B Dmitriyeva.   

Abstract

Hydrophobized and non-hydrophobized Fab fragments of human antibodies against gliofibrillar acid protein (GFAP) and brain specific alpha 2-glycoprotein (alpha 2GP) were used to study their penetration through the blood-brain barrier (BBB). These Fab fragments were modified by stearoyl chloride in reversed micelles of aerosol OT in octane (one or two fatty acid residues attached to protein molecule). Modified and non-modified 125I-labelled Fab fragments were intracardially administered to rats. The amount of label accumulated in brain was 55% higher than the total amount in all other organs. In contrast, non-hydrophobized Fab fragments did not penetrate through the BBB. We assume that the artificial hydrophobization of Fab fragments can increase their capability to penetrate through the cell membranes and, in particular, the BBB.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8742434

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

1.  Polyethylene-glycolated immunoliposomes specific for astrocytes.

Authors:  V P Chekhonin; Yu A Zhirkov; O I Gurina; I A Ryabukhin; S V Lebedev; I A Kashparov; D V Blinov; T B Dmitrieva
Journal:  Dokl Biochem Biophys       Date:  2003 Jul-Aug       Impact factor: 0.788

Review 2.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

3.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

4.  Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity.

Authors:  J Wang; D Shen; W C Shen
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.

Authors:  Elena V Batrakova; Serguei V Vinogradov; Sandra M Robinson; Michael L Niehoff; William A Banks; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2005 Jul-Aug       Impact factor: 4.774

6.  Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates.

Authors:  Jeff Wang; Daphne Wu; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.